Valentina Imperatore

Dr. Valentina Imperatore


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2018 in Experimental Cell Research
Verified
Journal Article
Closed access
ELElisa Landucci
Elisa Landucci
MBMargherita Brindisi
Margherita Brindisi
LBLaura Bianciardi
Laura Bianciardi
LCLorenza M. Catania
Lorenza M. Catania
SDSergio Daga
Sergio Daga
IMIlaria Meloni
Ilaria Meloni

25 February 2015 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
SASara Amitrano
Sara Amitrano
AMAnnabella Marozza
Annabella Marozza
SSSerena Somma
Serena Somma
Valentina ImperatoreValentina Imperatore
Valentina Imperatore
THTheodora Hadjistilianou
Theodora Hadjistilianou
Francesca ArianiFrancesca Ariani
Francesca Ariani
In about 50% of sporadic cases of retinoblastoma, no constitutive RB1 mutations are detected by conventional methods. However, recent research suggests that, at least in some of these cases, there is somatic mosaicism with respect to RB1 normal and mutant alleles. The increased availability of next generation sequencing improves our ability to detect the exact percentage of patients with mosaicism. Using this technology, we re-tested a series of 40 patients with sporadic retinoblastoma: 10 of them had been previously classified as constitutional heterozygotes, whereas in 30 no RB1 mutations had been found in lymphocytes. In 3 of these 30 patients, we have now identified low-level mosaic variants, varying in frequency between 8 and 24%. In 7 out of the 10 cases previously classified as heterozygous from testing blood cells, we were able to test additional tissues (ocular tissues, urine and/or oral mucosa): in three of them, next generation sequencing has revealed mosaicism. Present results thus confirm that a significant fraction (6/40; 15%) of sporadic retinoblastoma cases are due to postzygotic events and that deep sequencing is an efficient method to unambiguously distinguish mosaics. Re-testing of retinoblastoma patients through next generation sequencing can thus provide new information that may have important implications with respect to genetic counseling and family care.

Verified
Journal Article
Open access
PDF file
KRKathleen Rooney
Kathleen Rooney
MLMichael A. Levy
Michael A. Levy
SHSadegheh Haghshenas
Sadegheh Haghshenas
JKJennifer Kerkhof
Jennifer Kerkhof
DRDaniela Rogaia
Daniela Rogaia
PPPaolo Prontera
Paolo Prontera
The 22q11.2 deletion syndrome (22q11.2DS) is the most common genomic disorder in humans and is the result of a recurrent 1.5 to 2.5 Mb deletion, encompassing approximately 20–40 genes, respectively. The clinical presentation of the typical deletion includes: Velocardiofacial, Di George, Opitz G/BBB and Conotruncalanomaly face syndromes. Atypical deletions (proximal, distal or nested) are rare and characterized mainly by normal phenotype or mild intellectual disability and variable clinical features. The pathogenetic mechanisms underlying this disorder are not completely understood. Because the 22q11.2 region harbours genes coding for transcriptional factors and chromatin remodelers, in this study, we performed analysis of genome-wide DNA methylation of peripheral blood from 49 patients with 22q11.2DS using the Illumina Infinium Methylation EPIC bead chip arrays. This cohort comprises 43 typical, 2 proximal and 4 distal deletions. We demonstrated the evidence of a unique and highly specific episignature in all typical and proximal 22q11.2DS. The sensitivity and specificity of this signature was further confirmed by comparing it to over 1500 patients with other neurodevelopmental disorders with known episignatures. Mapping the 22q11.2DS DNA methylation episignature provides both novel insights into the molecular pathogenesis of this disorder and an effective tool in the molecular diagnosis of 22q11.2DS.

22 November 2017 in Human Mutation
Verified
Journal Article
Closed access
PDF file
SDSergio Daga
Sergio Daga
MBMargherita Baldassarri
Margherita Baldassarri
CRCaterina Lo Rizzo
Caterina Lo Rizzo
CFChiara Fallerini
Chiara Fallerini
Valentina ImperatoreValentina Imperatore
Valentina Imperatore
APAnna Maria Pinto
Anna Maria Pinto

1 November 2016 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
LBLaura Bianciardi
Laura Bianciardi
Valentina ImperatoreValentina Imperatore
Valentina Imperatore
EFErika Fernández-Vizarra
Erika Fernández-Vizarra
ALAngela Lopomo
Angela Lopomo
MFMicol Falabella
Micol Falabella
EFElisa Frullanti
Elisa Frullanti

17 April 2018 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
Valentina ImperatoreValentina Imperatore
Valentina Imperatore
APAnna Maria Pinto
Anna Maria Pinto
EGElisa Gelli
Elisa Gelli
ETEva Trevisson
Eva Trevisson
VMValeria Morbidoni
Valeria Morbidoni
Francesca ArianiFrancesca Ariani
Francesca Ariani